Your browser doesn't support javascript.
loading
Mix and Shake: A Mild Way to Drug-Loaded Lysozyme Nanoparticles.
Cao, Cheng; Tian, Linqing; Li, Joanna; Raveendran, Radhika; Stenzel, Martina H.
Afiliación
  • Cao C; School of Chemistry, The University of New South Wales, Sydney 2052, Australia.
  • Tian L; School of Chemistry, The University of New South Wales, Sydney 2052, Australia.
  • Li J; School of Chemistry, The University of New South Wales, Sydney 2052, Australia.
  • Raveendran R; School of Chemistry, The University of New South Wales, Sydney 2052, Australia.
  • Stenzel MH; School of Chemistry, The University of New South Wales, Sydney 2052, Australia.
ACS Appl Mater Interfaces ; 16(21): 27177-27186, 2024 May 29.
Article en En | MEDLINE | ID: mdl-38753304
ABSTRACT
Biocompatible nanoparticles as drug carriers can improve the therapeutic efficiency of hydrophobic drugs. However, the synthesis of biocompatible and biodegradable polymeric nanoparticles can be time-consuming and often involves toxic solvents. Here, a simple method for protein-based stable drug-loaded particles with a narrow polydispersity is introduced. In this process, lysozyme is mixed with hydrophobic drugs (curcumin, ellipticine, and dasatinib) and fructose to prepare lysozyme-based drug particles of around 150 nm in size. Fructose is mixed with the drug to generate nanoparticles that serve as templates for the lysozyme coating. The effect of lysozyme on the physicochemical properties of these nanoparticles is studied by transmission electron microscopy (TEM) and scattering techniques (e.g., dynamic light scattering (DLS) and small-angle X-ray scattering (SAXS)). We observed that lysozyme significantly stabilized the curcumin fructose particles for 7 days. Moreover, additional drugs, such as ellipticine and dasatinib, can be loaded to form dual-drug particles with narrow polydispersity and spherical morphology. The results also reveal that lysozyme dual ellipticine/dasatinib curcumin particles enhance the cytotoxicity and uptake on MCF-7 cells, RAW 264.7 cells, and U-87 MG cells due to the larger and rigid hydrophobic core. In summary, lysozyme in combination with fructose and curcumin can serve as a powerful combination to form protein-based stable particles for the delivery of hydrophobic drugs.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Muramidasa / Curcumina / Elipticinas / Nanopartículas / Dasatinib Límite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Muramidasa / Curcumina / Elipticinas / Nanopartículas / Dasatinib Límite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2024 Tipo del documento: Article País de afiliación: Australia
...